1029 - Increased Mortality in Hospital-Onset Carbapenem-Resistant Enterobacterales Bloodstream Infections

Thursday, October 12, 2023

3:15 PM – 3:27 PM US ET

Location: 102 AB

Co-Author(s)

AB

Angelique E. Boutzoukas, MD, MPH

Fellow, Pediatric Infectious Diseases
Duke University
Durham, North Carolina, United States
LK

Lauren Komarow, MS

Biostatistician
George Washington University
Rockville, Maryland, United States

Presenting Author(s)

Natalie A. Mackow, MD (she/her/hers)

Fellow
University of North Carolina
Chapel Hill, NC, United States

Slides

Co-Author(s)

AG

Abhigya Giri, MPH

Biostatistician
The George Washington University
Rockville, Maryland, United States
LC

Liang Chen, Ph.D

Dr.
HMH-CDI
Nutley, New Jersey, United States
CH

Carol Hill, PhD

Duke Clinical Research Institute
Durham, North Carolina, United States
Yohei Doi, MD, PHD

Professor of Medicine
University of Pittsburgh
Pittsburgh, PA, United States
Michael J. Satlin, MD

Associate Professor
Weill Cornell Medicine
New York, NY, United States
Cesar A. Arias, MD/PhD

Professor
Houston Methodist and Weill Cornell Medical College
Houston, TX, United States
MW

Minggui Wang, MD

Professor
Institute of Antibiotics, Huashan Hospital, Fudan University
Shanghai, Shanghai, China (People's Republic)
LM

Laura Mora Moreo, MD, MSc, PhD(c)

Department of Health Services Research and Policy, Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine
London, England, United Kingdom
EH

Erica Herc, MD

Senior Staff, Infectious Diseases
Henry Ford Hospital
Detroit, Michigan, United States
EC

Eric Cober, MD

Staff
Cleveland Clinic Foundation
Cleveland, OH, United States
Gregory D. Weston, MD, MSCR

Assistant Professor
Montefiore Medical Center and Albert Einstein College of Medicine
Bronx, NY, United States
Vance G. Fowler, MD, MHS

Professor of Medicine
Duke University Medical Center
Durham, NC, United States
David van Duin, MD, PhD

Professor of Medicine
University of North Carolina at Chapel Hill
Chapel Hill, NC, United States

Disclosure(s):

Yohei Doi, MD, PHD: bioMerieux: Advisor/Consultant (Ongoing); FujiFilm: Advisor/Consultant (Terminated, December 31, 2022); Gilead Biosciences: Advisor/Consultant (Ongoing), Honoraria (Ongoing); GSK: Advisor/Consultant (Ongoing); Meiji Seika Pharma Co., Ltd.: Advisor/Consultant (Ongoing); Moderna: Advisor/Consultant (Ongoing), Honoraria (Ongoing); MSD Sharp & Dohme: Advisor/Consultant (Terminated, December 31, 2022), Honoraria (Terminated, December 31, 2022); Shionogi: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing), Honoraria (Ongoing)

Michael J. Satlin, MD: AbbVie: IDMC member (); Biomerieux: Grant/Research Support (); Merck: Grant/Research Support (); SNIPRBiome: Grant/Research Support ()

Cesar A. Arias, MD/PhD: No financial relationships to disclose

Eric Cober, MD: No financial relationships to disclose

Vance G. Fowler, MD, MHS: Amphliphi Biosciences, Integrated Biotherapeutics; C3J, Armata, Valanbio; Akagera, Aridis, Roche, Astra Zeneca: Advisor/Consultant (); Genentech, Regeneron, Deep Blue, Basilea, Janssen;: Grant/Research Support (); Infectious Diseases Society of America: Honoraria (); MedImmune, Allergan, Pfizer, Advanced Liquid Logics, Theravance, Novartis, Merck; Medical Biosurfaces; Locus; Affinergy; Contrafect; Karius;: Grant/Research Support (); Novartis, Debiopharm, Genentech, Achaogen, Affinium, Medicines Co., MedImmune, Bayer, Basilea, Affinergy, Janssen, Contrafect, Regeneron, Destiny,: Advisor/Consultant (); Sepsis diagnostic: Patent pending (); UpToDate: Royalties (); Valanbio and ArcBio: Stock Options ()

David van Duin, MD, PhD: Entasis: Advisor/Consultant (Terminated, August 24, 2021), Honoraria (Terminated, August 24, 2021); Merck: Advisor/Consultant (Ongoing), Grant/Research Support (Ongoing); pfizer: Honoraria (Terminated, March 17, 2022); Qpex: Advisor/Consultant (Terminated, February 18, 2023); Roche: Advisor/Consultant (Ongoing); Shionogi: Advisor/Consultant (Terminated, February 16, 2023), Grant/Research Support (Terminated, February 16, 2023)